“Devyser reports continued strong sales growth and high gross margins for the quarter. It is particularly pleasing to see that our investment in the
Fredrik Alpsten, CEO, Devyser
The quarter from January to
- Net sales amounted to
SEK 50.7 million (39.5), corresponding to a 28.5 percent increase. Adjusted for exchange rate fluctuations, net sales increased by 27.7 percent. - Gross profit totaled
SEK 41.9 million (33.7), corresponding to a gross margin of 82.7 percent (85.2). - Operating profit (EBIT) amounted to
SEK -12.2 million (-19.1). - Profit after tax totaled
SEK -12.2 million (-19.9). - Earnings per share before and after dilution amounted to
SEK -0.75 (-1.24). - Cash flow from operating activities stood at
SEK -16.5 million (-19.3).
Important events during the quarter
IVD development agreement with
In early January, a contract was signed with Illumina for IVD (in vitro diagnostics) development. This was to enable US and European regulatory registrations of Devyser’s NGS tests on MiSeqDx, Illumina’s FDA-regulated and CE-IVD-marked sequencing instrument.
Devyser strengthened its management team
The management team was expanded on
Important events after the end of the quarter
Devyser granted MDSAP certification in
In April, Devyser was granted MDSAP (Medical Device Single Audit Program) certification for its quality management system in
Devyser enters into a partnership with Hamilton for the automation of NGS workflows in laboratories
In April, a joint marketing agreement was signed with
Devyser granted IVDR approval for post-transplant monitoring software
In April, Devyser was granted IVDR approval for its Advyser Solid Organs software, which is used with the One Lambda Devyser Accept cfDNA product for post-transplant monitoring. This is Devyser's first IVDR-certified software to be approved in
The share and new issues
In April, two new share issues were carried out in connection with the exercising of warrants and employee stock options. The issues raised
Presentation
The report will be presented at an audiocast at
This report and previous financial reports are available on the company’s webpage https://investors.devyser.com/en/reports-presentations.
© Modular Finance, source